Author: Wu Yin Pfeifer Andreas Klaus Myschetzky Rebecca Garbyal Rajendra Singh Rasmussen Palle Knigge Ulrich Bzorek Michael Kristensen Michael Holmsgaard Kjaer Andreas
Publisher: MDPI
E-ISSN: 2075-4418|3|4|344-355
ISSN: 2075-4418
Source: Diagnostics, Vol.3, Iss.4, 2013-10, pp. : 344-355
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Peptide receptor radionuclide therapy (PRRT) is a relatively new mode of internally targeted radiotherapy currently in clinical trials. In PRRT, ionizing radioisotopes conjugated to somatostatin analogues are targeted to neuroendocrine tumors (NETs) via somatostatin receptors. Despite promising clinical results, very little is known about the mechanism of tumor control. By using NCI-H727 cells in an
Related content
By Ahlstedt Jonas Tran Thuy A. Strand Sven-Erik Gram Magnus Åkerström Bo
International Journal of Molecular Sciences, Vol. 16, Iss. 12, 2015-12 ,pp. :
By Cacan Ercan Spring Alexander M. Kumari Anita Greer Susanna F. Garnett-Benson Charlie
International Journal of Molecular Sciences, Vol. 16, Iss. 12, 2015-12 ,pp. :
Modulation of the Anti-Tumor Efficacy of Photodynamic Therapy by Nitric Oxide
Cancers, Vol. 8, Iss. 10, 2016-10 ,pp. :
By Tsai Lydia K. Pop Laurentiu M. Liu Xiaoyun Vitetta Ellen S.
Toxins, Vol. 3, Iss. 4, 2011-04 ,pp. :